Tests a combination pill for high blood pressure and high cholesterol
Tests a combined pill in adults with high blood pressure and high cholesterol.
Plain-language title generated from the registry record
Registry title: To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia
Key facts
- Where
- Seoul, South KoreaSee the site
- Phase
- Phase 3
Where in South Korea
- Hanyang University HospitalSeoul, South KoreaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Hyundai Pharm
- Trial code
- NCT06646354
- Record updated
- 22 May 2025
- Original description
A Multicenter, Randomized, Double-blind, Active-controlled, Parallel group, Phase 3 trial to Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients with Essential Hypertension and Primary HypercholesterolemiaRead full original descriptionShow less
A Multicenter, Randomized, Double-blind, Active-controlled, Parallel Group, Phase 3 Trial to Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia
A Multicenter, Randomized, Double-blind, Active-controlled, Parallel group, Phase 3 trial to Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients with Essential Hypertension and Primary Hypercholesterolemia
Inclusion: Age ≥ 19; Patients with Essential Hypertension and Primary Hypercholesterolemia.
Exclusion: Patients with differences between arms greater than 20 mmHg for mean sitSBP or 10 mmHg for mean sitDBP; Patients with mean sitSBP ≥ 180 mmHg or mean sitDBP ≥ 110 mmHg.